|
Aug 6
|
Wall Street Analysts Think Pharming Group (PHAR) Could Surge 145.75%: Read This Before Placing a Bet
|
|
Aug 4
|
Pharming Group to participate in August investor conference
|
|
Aug 2
|
Pharming Group Second Quarter 2025 Earnings: EPS: US$0.007 (vs US$0.002 loss in 2Q 2024)
|
|
Aug 1
|
New Strong Buy Stocks for August 1st
|
|
Jul 31
|
Pharming Group reports second quarter and first half 2025 financial results and provides business update
|
|
Jul 29
|
High Growth Tech Stocks To Watch In Europe July 2025
|
|
Jul 25
|
Best Momentum Stocks to Buy for July 25th
|
|
Jul 22
|
Leigh Syndrome Market Research Report 2025-2035 | Competitive Analysis of PTC Therapeutics, Pharming Group, Edison Pharmaceuticals, Taysha Gene Therapies, and Thiogenesis Therapeutics
|
|
Jul 22
|
Preeclampsia Drug Market Research Report 2025-2035 | Competitive Analysis of Pharming Group, AMAG Pharmaceuticals, Kyowa Kirin, and Baxter
|
|
Jul 17
|
New Strong Buy Stocks for July 17th
|
|
Jul 17
|
Pharming Group to report second quarter and first half 2025 financial results and provide business update on July 31
|
|
Jul 15
|
Uncovering Opportunities: AROBS Transilvania Software And 2 Other Promising European Penny Stocks
|
|
May 28
|
Pharming Group to participate in June investor conferences
|
|
Mar 14
|
Pharming Group (PHGUF) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
|
|
Mar 14
|
3 European Penny Stocks With Market Caps Over €300M
|
|
Mar 14
|
Pharming Group Full Year 2024 Earnings: EPS Beats Expectations
|
|
Mar 13
|
Pharming Group reports fourth quarter and full year 2024 financial results and provides business update
|
|
Feb 20
|
Pharming Technologies B.V. increases its ownership in Abliva AB (publ) to 92.70 percent
|
|
Oct 10
|
Pharming Group to report third quarter 2024 financial results on October 24
|
|
Aug 9
|
Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan
|